The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0

ConclusionsOur study quantified the representativeness of multiple type 2 diabetes trials. The common low representativeness of type 2 diabetes trials could be attributed to specific study design requirements of trials or safety concerns. Rather than criticizing the low representativeness, we contribute a method for increasing the transparency of the representativeness of clinical trials.
Source: Journal of the American Medical Informatics Association - Category: Information Technology Source Type: research